bg img

Antibody Engineering & Therapeutics Conference

  • December 12th 2021 - September 16th 2021
  • 9:05am – 9:35am CEST
    8:05am – 8:35am BST
    3:05am – 3:35am EDT
    12:05am – 12:35am PDT
  • Marriott Marquis San Diego, Marriott Marquis San Diego
  • Event website
SHARE THIS EVENT

Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile scientific environments.

Antibody Engineering & Therapeutics Conference

Arrange to Meet Us


Introduction

The #1 Antibody Engineering Conference For Accelerating Next Generation Antibodies To Commercial Success

Discover the Latest Innovations in Science on Antibody Discovery, Engineering Cytokines, Drug Conjugates, Immunotherapy, Machine Learning and Much More…

Join Christian and Colby for their talk on ‘Hit Expansion for Antibody Discovery’

Talk Abstract:
Lead candidate identification in antibody discovery may encounter potential bottlenecks at multiple phases. Regardless of the technology employed for hit identification and characterization, a critical step is the resolution of paired heavy and light chain variable gene sequences and correlation to empirical data. Selecting the right candidate from an abundance of information is a non-trivial task that necessitates the use of advanced data analysis tools. This presentation will highlight a diverse set of initial candidate antibodies that are effectively triaged using a combination of screening data and bioinformatic methods to identify those with the most favorable activity and stability. Further, the presentation will introduce an in silico guided hit expansion workflow that provides additional, naturally derived antibody diversity through NGS repertoire analysis.

Date & Time:
Tue Dec 14 @ 12:05-12:35pm PST

Map
Speakers and Panelists
Avatar

Christian Olsen

Solutions Architect, Insightful Science

Christian worked at Seattle Biomed and the Seattle Structural Genomics Center for Infectious Disease in the bioinformatics core, supporting institute researchers, and collaborating with EupathDB, the University of Washington, the Wellcome Sanger Institute, and the London School of Health and Tropical Medicine. After Seattle BioMed, Christian worked at Biomatters as a Field Application Scientist supporting Geneious Prime users in the U.S. and the EU. After Biomatters, Christian next worked with Pacific Biosciences as a Senior Scientist for infectious disease (human applications). Christian joined Insightful Science in 2020 as a Solutions Architect in support of Insightful Science's software portfolio.

View bio less
Avatar

Colby Souders

Chief Scientific Officer, Abveris

Colby Souders holds a PhD in Cell and Molecular Biology from Texas A&M and prior to Abveris was part of MassBiologics of the University of Massachusetts Medical School and Kanyos Bio (now Anokion). At MassBiologics, he worked to advance monoclonal antibodies for the prevention, treatment or diagnosis of various infectious and endogenous diseases, as well as develop related platform technologies to advance and expand the MassBiologics pipeline. Later, he joined the Kanyos Bio Protein Engineering team to develop therapeutics based on a novel antigen-specific immune tolerance platform. With the successful completion of multiple antibody discovery, affinity maturation and protein engineering campaigns that helped advance lead molecules to clinical trials, Colby joined Abveris in August of 2018. As Chief Scientific Officer, he helps guide the team to usher in a new generation of antibody discovery tools and build a premium discovery engine with industry-leading timelines.

View bio less

Arrange to Meet Us

SHARE THIS EVENT

Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile scientific environments.